US20210350723A1 - Patient-specific cardiovascular simulation device - Google Patents

Patient-specific cardiovascular simulation device Download PDF

Info

Publication number
US20210350723A1
US20210350723A1 US17/278,049 US201917278049A US2021350723A1 US 20210350723 A1 US20210350723 A1 US 20210350723A1 US 201917278049 A US201917278049 A US 201917278049A US 2021350723 A1 US2021350723 A1 US 2021350723A1
Authority
US
United States
Prior art keywords
patient
tank
specific
simulation device
surgical simulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US17/278,049
Other languages
English (en)
Inventor
Pierre-Benoît PIRLOT
Frédéric Champ
Noémi Renaudin
Frédéric PIASEK
Armand DOLUI
Clément Jubert
Baptiste Luciani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomodex Sas
Original Assignee
Biomodex Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomodex Sas filed Critical Biomodex Sas
Priority to US17/278,049 priority Critical patent/US20210350723A1/en
Publication of US20210350723A1 publication Critical patent/US20210350723A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • G09B23/285—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine for injections, endoscopy, bronchoscopy, sigmoidscopy, insertion of contraceptive devices or enemas
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • G09B23/286—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine for scanning or photography techniques, e.g. X-rays, ultrasonics
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • G09B23/30—Anatomical models
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • G09B23/30—Anatomical models
    • G09B23/303—Anatomical models specially adapted to simulate circulation of bodily fluids
    • G—PHYSICS
    • G09—EDUCATION; CRYPTOGRAPHY; DISPLAY; ADVERTISING; SEALS
    • G09B—EDUCATIONAL OR DEMONSTRATION APPLIANCES; APPLIANCES FOR TEACHING, OR COMMUNICATING WITH, THE BLIND, DEAF OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; DIAGRAMS
    • G09B23/00—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes
    • G09B23/28—Models for scientific, medical, or mathematical purposes, e.g. full-sized devices for demonstration purposes for medicine
    • G09B23/30—Anatomical models
    • G09B23/34—Anatomical models with removable parts

Definitions

  • This disclosure is directed simulation devices, and more particularly, to patient-specific cardiovascular simulation devices.
  • Heart disease is the leading cause of mortality and morbidity in the modern world.
  • Numerous mini-invasive therapies such as percutaneous or transcatheter interventions have recently been introduced for treatment of structural heart disease (SHD).
  • SHD structural heart disease
  • SHD teams there are limited opportunities and tools for SHD teams to plan and practice any structural heart intervention in the cardiac catheterization laboratory environment.
  • a simulation device that mimics cardiovascular anatomical structures for training and planning interventional cardiology procedures.
  • the simulation device can include a frame and a multi-material patient-specific cardiac model with accurate biomechanical properties and variable echogenic materials.
  • the variable echogenic materials may be visible on ultrasound imaging, with visual aspects close to those of biological tissues.
  • a surgical simulation device includes a patient-specific cartridge that includes a patient-specific model of at least a portion of a heart of a patient, the patient-specific model including at least a portion configured to mimic an anatomical shape and a mechanical behavior of the portion of the heart of the patient; a station having a housing; a tank formed in the housing and configured to receive the patient-specific cartridge; an esophageal access system extending within the housing between an esophageal access port on the housing and a first port in the tank; and a vascular access system comprising a first end with a vascular access port and a second end configured to be fluidly coupled to a second port in the tank.
  • a patient-specific cartridge for a surgical simulator device including a patient-independent frame having first, second, and third openings; and a patient-specific cardiac model.
  • the patient-specific cardiac model includes a right atrium; a left atrium and a septum having mechanical and anatomical shape properties that correspond to the mechanical and anatomical shape properties of the left atrium and the septum of a patient; a superior vena cava interfacing portion that deviates from the anatomical shape of the superior vena cava of the patient and extends between the right atrium and the first opening in the patient-independent frame; an inferior vena cava interfacing portion that deviates from the anatomical shape of the inferior vena cava of the patient and extends between the right atrium and the second opening in the patient-independent frame; and an upper pulmonary vein interfacing portion that deviates from the anatomical shape of the pulmonary vein of the patient and extends between the left atrium and the third opening in the
  • a surgical simulation device includes a station having a housing; a tank formed in the housing and configured to receive a patient-specific cartridge that includes a patient-specific model of at least a portion of a heart of a patient, wherein the tank comprises a bottom wall having a first surface that forms a bottom surface of the tank, and an opposing second surface; an esophageal access system extending within the housing between an esophageal access port on the housing and a first port in the tank; a vascular access system including a first end with a vascular access port and a second end configured to be fluidly coupled to a second port in the tank; and a spinal shadow simulation card disposed within the housing adjacent the opposing second surface of the bottom wall of the tank.
  • a method includes providing a surgical simulation device having a station having a housing, a tank formed in the housing, and a vascular access system coupled to the housing; providing, in the tank, a patient-specific cartridge that includes a patient-specific model of at least a portion of a heart of a patient; inserting an imaging device through an esophageal access system within the housing from an esophageal access port on the housing, though a first port in the tank, and into a recess in a bottom surface of the tank beneath the patient-specific cartridge; and inserting a surgical element from a vascular access port of the vascular access system, through a main lumen of the vascular access system, and into a portion of the patient-specific model via a second port in the tank.
  • a surgical simulation device includes a patient-specific cartridge that replicates anatomical and acoustic features of an organ of a specific patient; a station including a tank configured to receive the patient-specific cartridge; a surgical access system coupled to the station and including a lumen extending from a surgical access port to an access port for the tank, the lumen configured to simulate a blood vessel of a generic patient; and an imaging access system extending within the station from an imaging access port to the tank, the imaging access system comprising a lumen configured to simulate an imaging access pathway within the generic patient.
  • the imaging access system mimics an esophagus of a generic patient, and provides access to a transesophageal echocardiography probe.
  • FIG. 1 illustrates various interventional cardiac procedures that can be simulated with a physical simulator device according to aspects of the disclosure.
  • FIG. 2 illustrates an exemplary catheterization (Cath) lab including a physical simulator device, according to aspects of the disclosure.
  • FIG. 3 illustrates a physical simulator device overlaid on a representation of a patient, according to aspects of the disclosure.
  • FIG. 4 illustrates various locations on a septum of a heart for a transseptal puncture for various procedures.
  • FIGS. 5A and 5B illustrate further details of a physical simulator device, according to aspects of the disclosure.
  • FIG. 6 illustrates a perspective view of a physical simulator device, according to aspects of the disclosure.
  • FIG. 7 illustrates a cross-sectional side view of a station of a physical simulator device, according to aspects of the disclosure.
  • FIG. 8 illustrates a side view, aligned with and overlaid on a representation of a patient, of a station of a physical simulator device, according to aspects of the disclosure.
  • FIG. 9 illustrates a cross-sectional side view of an esophageal access system of a physical simulator device, according to aspects of the disclosure.
  • FIG. 10 illustrates a cross-sectional side view of the station of a physical simulator device, according to aspects of the disclosure.
  • FIG. 11 illustrates a side view representation of a physical simulator device including a patient-specific cartridge, according to aspects of the disclosure.
  • FIG. 12 illustrates a cross-sectional end view of a lumen of a physical simulator device, according to aspects of the disclosure.
  • FIG. 13 illustrates a perspective view of a portion of an esophageal access system of a physical simulator device, according to aspects of the disclosure.
  • FIG. 14 illustrates a top view of a portion of a physical simulator device, according to aspects of the disclosure.
  • FIGS. 15A and 15B illustrate exploded perspective and perspective views of a vascular access device of a physical simulator device, according to aspects of the disclosure.
  • FIGS. 16A and 16B illustrate side and top views of the vascular access device of a physical simulator device, according to aspects of the disclosure.
  • FIG. 17 illustrates a cross-sectional top view of a physical simulator device, according to aspects of the disclosure.
  • FIG. 18 illustrates a perspective view of an access port of a station of a physical simulator device, according to aspects of the disclosure.
  • FIG. 19 illustrates through holes of the access port of FIG. 18 , according to aspects of the disclosure.
  • FIG. 20 illustrates a perspective view of a housing of a station of a physical simulator device, according to aspects of the disclosure.
  • FIG. 21 illustrates another perspective view of the housing of the station of a physical simulator device, according to aspects of the disclosure.
  • FIG. 22 illustrates an acoustic coating for a tank of station of a physical simulator device, according to aspects of the disclosure.
  • FIG. 23 illustrates ultrasound images obtained with and without an acoustic coating in a tank of a physical simulator device, according to aspects of the disclosure.
  • FIG. 24 illustrates a cross-sectional side view of a tank of station of a physical simulator device, according to aspects of the disclosure.
  • FIG. 25 illustrates a perspective view of a patient-specific cartridge of a physical simulator device, according to aspects of the disclosure.
  • FIGS. 26A and 16B illustrate perspective and top views of another patient-specific cartridge of a physical simulator device, according to aspects of the disclosure.
  • FIG. 27 illustrates features of a fossa ovalis of a patient-specific model of a patient-specific cartridge of a physical simulator device, according to aspects of the disclosure.
  • FIG. 28 illustrates ultrasound images of a patient-specific model in a tank of a physical simulator device, which may be obtained using an ultrasound device disposed in the tank of the physical simulator device, according to aspects of the disclosure.
  • FIG. 29 illustrates a left atrial appendage of a patient-specific model of a patient-specific cartridge of a physical simulator device, according to aspects of the disclosure.
  • FIG. 30 illustrates a portion of a patient heart that can be modeled by a patient-specific model of a patient-specific cartridge of a physical simulator device, according to aspects of the disclosure.
  • FIG. 31 illustrates a perspective view of a patient-specific cartridge having a patient-independent frame, according to aspects of the disclosure.
  • FIG. 32 illustrates a perspective view of a patient-independent frame for a patient-specific cartridge, according to aspects of the disclosure.
  • FIG. 33 illustrates a perspective view of a patient-specific cartridge having a patient-specific model coupled to a patient-independent frame, according to aspects of the disclosure.
  • FIG. 34 illustrates another perspective view of a patient-specific cartridge having another patient-specific model coupled to a patient-independent frame, according to aspects of the disclosure.
  • FIG. 35 illustrates a patient-specific model, according to aspects of the disclosure.
  • FIG. 36 illustrates another perspective view of a patient-independent frame of a patient-specific cartridge coupled to various different patient-specific models, according to aspects of the disclosure.
  • FIG. 37 illustrates a coupling portion of a patient-specific model for coupling to a patient-independent frame, according to aspects of the disclosure.
  • FIGS. 38A and 38B respectively illustrate misaligned patient portions and corresponding coupling portions of a patient-specific model for coupling to a patient-independent frame, according to aspects of the disclosure.
  • FIG. 39 illustrates another example of misaligned patient portions and corresponding coupling portions of a patient-specific model for coupling to a patient-independent frame, according to aspects of the disclosure.
  • FIG. 40 illustrates various aspects of a process for manufacturing a patient-specific cardiac model for coupling to a patient-independent frame, according to aspects of the disclosure.
  • FIG. 41 illustrates a fluoroscopic image of a surgical instrument in a portion of a patient's heart, according to aspects of the disclosure.
  • FIG. 42 illustrates a fluoroscopic image of a surgical instrument in a patient-specific model of a patient's heart, according to aspects of the disclosure.
  • FIG. 43 illustrates a cross-sectional view of a portion of a wall of a patient-specific model of a patient's heart, according to aspects of the disclosure.
  • FIG. 44 illustrates a cross-sectional view of a portion of a coated wall of a patient-specific model of a patient's heart, according to aspects of the disclosure.
  • FIG. 45 illustrates a process for injecting an x-ray reactive material into a wall of a patient-specific model of a patient's heart, according to aspects of the disclosure.
  • FIG. 46 illustrates a perspective view of a spinal shadow card, according to aspects of the disclosure.
  • FIG. 47 illustrates a side view of a station of a physical simulator device with a spinal shadow card, according to aspects of the disclosure.
  • FIG. 48 illustrates a schematic view of a fluid flow system of a physical simulator device, according to aspects of the disclosure.
  • FIG. 49 illustrates a schematic view of another fluid flow system of a physical simulator device, according to aspects of the disclosure.
  • FIG. 50 illustrates a schematic view of a fluid heating system of a physical simulator device, according to aspects of the disclosure.
  • FIG. 51 illustrates a perspective view of an accessory fluid heater for a physical simulator device, according to aspects of the disclosure.
  • FIG. 52 illustrates a cross-sectional view of a mounting member of an accessory fluid heater for a physical simulator device, according to aspects of the disclosure.
  • FIG. 53A illustrates a perspective view of another accessory fluid heater for a physical simulator device, according to aspects of the disclosure.
  • FIG. 53B illustrates a cross-sectional view of a mounting portion of the accessory fluid heater of FIG. 53A , according to aspects of the disclosure.
  • FIG. 53C illustrates a cross-sectional view of a mounting portion and a heating element of the accessory fluid heater of FIG. 53A , according to aspects of the disclosure.
  • FIG. 54 illustrates a perspective view of a flush system for a physical simulator device, according to aspects of the disclosure.
  • FIGS. 55 and 56 illustrate schematic views of respective open and closed arrangements of a portion of a fluid flow system of a physical simulator device for coupling to the flush system of FIG. 54 , according to aspects of the disclosure.
  • FIG. 57 illustrates a cross-sectional view of a Y-pipe of a fluid flow system of a physical simulator device for coupling to the flush system of FIG. 54 , according to aspects of the disclosure.
  • FIG. 58 illustrates a schematic side view of a patient-specific cartridge during installation in a tank of a station of a physical simulator device, according to aspects of the disclosure.
  • FIG. 59 illustrates a schematic side view of a patient-specific cartridge installed in a tank of a station of a physical simulator device, according to aspects of the disclosure.
  • FIG. 60 illustrates a schematic perspective view of securement members on a frame of a patient-specific cartridge, according to aspects of the disclosure.
  • FIG. 61 illustrates a schematic perspective view of securement members on a sidewall of a tank of station, according to aspects of the disclosure.
  • FIG. 62 illustrates a schematic side view of a securement interaction between securement members on a sidewall of a tank of station and corresponding securement members of a frame of a patient-specific cartridge, according to aspects of the disclosure.
  • FIG. 63 illustrates a schematic side view of a securement interaction between an access port of a tank of station and a distal support of a frame of a patient-specific cartridge, according to aspects of the disclosure.
  • Interventional cardiologists work with fluoroscopy as the main tool for real-time guidance of catheter-based therapy. Since interventions in structural heart disease (SHD) are performed on the beating heart, visualization of the relevant structures with means other than direct visual inspection by the surgeon is crucial. Advances in cardiac imaging with three-dimensional transesophageal echocardiography (TEE) have proven particularly helpful in demonstrating the complex cardiac morphology and in performing necessary pre-interventional precise measurements for planning and tailoring of percutaneous therapies.
  • SHD structural heart disease
  • TEE transesophageal echocardiography
  • Virtual and physical simulators offer the opportunity to train for a procedure before actions can influence patient out-comes, insulating patients from risk during the novice operator period.
  • the use of simulators also reduces training time and facilitates more structured, comprehensive skill acquisition when compared to the classical apprenticeship model.
  • existing simulation devices for training and/or planning do not reproduce a realistic biomechanical behavior and/or are not visible on ultrasound imaging with visual aspects close to those of biological tissues.
  • SHD Structural Heart Diseases
  • FIG. 1 shows part of a 2016 Mayo Clinic® graphic which illustrates eight structural heart interventions (labeled A-H) that are performed, in part, by inserting one or more of the specially designed catheters, guides, sheaths, and implantation tools from the inferior vena cava 110 into the right atrium 101 of a heart 100 of a patient, then into the left atrium 102 via a transseptal puncture through the septum 112 .
  • these interventions can be performed to manipulate and/or address issues with the mitral valve between the left atrium 102 and the left ventricle 104 , the pulmonary vein 114 , and/or the left atrial appendage 116 (as examples).
  • the transseptal puncture may be formed at different locations on the septum 112 for different procedures.
  • SHD interventions are complex, and numerous guidelines recommend the implementation of a multidisciplinary SHD team rather than a single person.
  • the SHD team typically consists of cardiologists and cardiac interventionalists, a cardiac surgeon, cardiovascular imaging specialists, anesthesiologists, and specialized nurses.
  • the action of the intervening specialists heavily depends on images offered by the imaging specialist, who in turn needs to know the structures relevant to the interventionalist and what views are optimal for guiding the procedure. Identifying structures simultaneously on echocardiographic and fluoroscopic imaging is complicated and prone to miscommunication.
  • a physical simulation device which accurately replicates a specific patient's anatomy and cardiac wall mechanical behavior, and, when imaged using ultrasound imaging, generates images with visual aspects that are close to the corresponding visual aspects of the corresponding biological tissues of the patient under ultrasound imaging.
  • the physical simulator device can include a station that includes a housing having a tank within which a patient-specific cardiac model can be disposed, an esophageal access system within the housing, and a vascular access system coupled to the housing. A patient-specific cartridge can be placed into the tank.
  • the cartridge includes a patient-independent frame and a multi-material patient-specific cardiac model with realistic biomechanical properties and that is visible on ultrasound imaging with an aspect that is close to the corresponding aspect of corresponding biological tissues.
  • the simulator system e.g., including the station and the cartridge
  • the simulator system can be arranged to mimic the characteristics (e.g., the geometry, acoustic impedance and biomechanics) of the human right and left atrium, and to fit the environment of a non-sterile operating room (e.g., a Cath lab) without the presence of any patient.
  • FIG. 2 illustrates a Cath lab 200 implementing a simulator system that includes a physical simulator device 202 (e.g., supported on a Cath lab table 210 ), an imaging system 204 (e.g., a fluoroscopy system), an ultrasound system 208 (e.g., an ultrasound imaging system), and a display 206 on which images such as ultrasound and fluoroscopy images of a cartridge within a tank of the station of the physical simulator device 202 can be seen.
  • a physical simulator device 202 e.g., supported on a Cath lab table 210
  • an imaging system 204 e.g., a fluoroscopy system
  • an ultrasound system 208 e.g., an ultrasound imaging system
  • a display 206 on which images such as ultrasound and fluoroscopy images of a cartridge within a tank of the station of the physical simulator device 202 can be seen.
  • FIG. 3 Details of the physical simulator device 202 are shown in FIG. 3 .
  • physical simulator device 202 is shown in superimposed over a depiction 399 of a human body so that the alignment between various features of the physical simulator device 202 and body of a patient can be seen.
  • FIG. 3 shows show the physical simulator device 202 may include a station 300 having a tank 306 arranged to receive a patient-specific cartridge 308 that mimics the mechanical and acoustic features of at least portions of a heart of a particular patient.
  • the tank 306 is positioned relative to an esophageal access port 304 and vascular access port 310 , in accordance with the relative positions of the patient's heart relative to the patient's mouth and a femoral vein puncture location.
  • the arrangement of the physical simulator device 202 mimics the relative locations of the organ to be operated on (e.g., the heart), an ultrasound access point (e.g., the patient's mouth), and a vascular access port (e.g., along the femoral vein).
  • the physical simulator device 202 includes a vascular access system 302 coupled to the station 300 , and having a curvature that allows the vascular access system 302 to mimic a portion of the femoral vein, the right external and common iliac veins 312 , and the vena cava 314 leading to the right atrium of the simulated patient heart in cartridge 308 .
  • the combination of the cartridge 308 and the station 300 aim to achieve the functionality of all the anatomical parts needed for a Left Atrial Appendage (LAA) closure intervention.
  • the station 300 and a frame of the cartridge 308 may represent standard anatomical parts (e.g., of a generic patient) and a patient-specific model of the cartridge 308 may represent the patient-specific anatomical parts.
  • the LAA closure intervention starts with a puncture at a port 310 in the femoral vein replica (e.g., a standard-patient part), and then a guidewire is installed through the replica to the right atrium replica of the heart simulated by cartridge 308 .
  • the catheter enters the cartridge 308 , which includes the patient-specific part of the system.
  • FIG. 4 is a portion of a Mayo Clinic® image that illustrates a location 408 on the fossa ovalis 400 for the transseptal puncture for a LAA procedure.
  • Other locations on the fossa ovalis 400 are also shows for transseptal punctures for other procedures, such as a location 404 for a transseptal patent foramen ovale closure, a location 402 for a paravalvular leak closer, a location 406 for a percutaneous left ventricular assist device placement, and a location 410 for a pulmonary vein intervention.
  • Cartridge 308 includes a patient-specific model, in which the position and the shape of the fossa ovalis is patient specific.
  • the mechanical features of the patient-specific model such as the mechanical response of the modeled fossa ovalis to external forces (e.g., forces exerted by surgical instruments) may be patient-specific to mimic the mechanical response of the corresponding tissue of the patient's heart, responsive to the same forces.
  • the thickness and/or material properties of portions of the model e.g., the fossa ovalis
  • the cardiologist pushes the guidewire inside the patient-specific upper pulmonary vein replica of the cartridge 308 . Then the surgeon pulls on the catheter, crosses the ridge between the replicated pulmonary vein and ends in the LAA, and deploys the device.
  • the cartridge 308 is positioned within the tank 306 disposed within the station 300 , and submerged in a fluid 307 (e.g., water or a blood mimicking fluid) in the tank 306 , so that the simulated tissue and interventional tools can be seen under ultrasound imaging (as described in further detail hereinafter).
  • Station 300 may also include fluid control systems for circulating, flushing, filtering, heating, and/or otherwise manipulating the blood mimicking fluid 307 , as described in further detail hereinafter.
  • FIGS. 5A and 5B show additional views of features of the physical simulator device 202 during a simulated LAA procedure (e.g., in a simulated fluoroscopic view representing the appearance of aspects of the system under x-ray imaging).
  • an ultrasound probe 505 e.g., a transesophageal echocardiographic (TEE) ultrasound probe
  • TEE transesophageal echocardiographic
  • operational components 501 e.g., pumps for moving fluid through the physical simulator device 202
  • the ultrasound device 505 has been inserted, via an esophageal access system within the station, under the cartridge 308 in the tank 306 .
  • Guidewire 507 has been inserted via vascular access device 302 , through into a portion of the patient-specific cartridge 308 .
  • cartridge 308 can be seen with a delivery device for an LAA closure device 502 having been passed through a transseptal puncture 511 in a simulated septum 112 ′ to close the simulated LAA 116 ′.
  • a position marker 500 on the delivery device can also be seen.
  • FIG. 6 illustrates a perspective view of the physical simulator device 202 , according to aspects of the disclosure.
  • housing 309 of station 300 can be seen coupled to a surgical access device such as vascular access system 302 .
  • vascular access port 310 at the proximal end of the vascular access system 302 can be seen.
  • Tank 306 in the housing 309 of station 300 can also be seen.
  • the station 300 and/or vascular access system 302 may be arranged to represent certain standard (i.e., non-patient specific) anatomical parts involved in a simulated intervention.
  • the primary functions of the station 300 are to hold the cartridge 308 (e.g., including the patient-specific cardiac model) in an anatomically relevant position, circulate fluid through the cartridge 308 to simulate blood flow, and provide anatomically realistic vascular and esophageal access.
  • the simulated vascular access provided by vascular access system 302 simulates the right femoral vein, iliac vein, and inferior vena cava access.
  • the simulated esophageal access can be disposed within housing 309 and provides a path for insertion and placement of, for example, a transesophageal echocardiographic (TEE) ultrasound probe for imaging the simulated procedure.
  • TEE transesophageal echocardiographic
  • a pump e.g., implemented as one of components 501 of FIG. 5
  • the pump can also purge the station 300 of fluid post procedure.
  • the station 300 and vascular access device 302 are designed to be positionable on a Cath Lab patient bed with all components being positioned in corresponding anatomical positions of a patient on the bed, as depicted in FIG. 3 .
  • the station 300 includes a main housing 309 surrounding the pump (e.g., pump 501 ), the tank 306 (in which the cartridge can be positioned), an imaging access system such as a replicated esophageal access system (also referred to herein as a TEE approach system), and a catheterization path channel.
  • a physical simulator device for simulating procedures for other organs of bodily features can also be provided with station, a tank, a patient-specific cartridge corresponding to the organ, a surgical access device for simulating interventional access to the organ, and an imaging access device for simulating imaging component access to the organ, without departing from the scope of the disclosure.
  • the physical simulator device 202 may be implemented with as a surgical simulation device that includes a patient-specific cartridge 308 that replicates anatomical and acoustic features of an organ (e.g., a heart, a lung, a stomach, a urinary bladder, a bone, a lymph node, a larynx, a pharynx, muscle vasculature, a spinal column, an intestine, a colon, a rectum, or an eye) of a specific patient, a station 300 including a tank 306 configured to receive the patient-specific cartridge 308 , a surgical access system 302 coupled to the station 300 and including a lumen 1700 extending from a surgical access port 310 to an access port 718 for the tank 306 , the lumen 1700 configured to simulate a blood vessel of a generic patient, and an imaging access system 700 extending within the station 300 from an imaging access port 304 to the tank 306 , the imaging access system comprising a lumen 900 configured to simulate
  • FIG. 7 illustrates a cross-sectional side view of a station 300 with an imaging access system implemented as an esophageal access system 700 .
  • esophageal access system 700 extends, within housing 309 , from a proximal end 710 at the imaging access port 304 on housing 309 to a distal end 714 within the housing.
  • the distal end 714 forms a port in the tank 306 that allows an imaging device, such as a TEE device, to be extended into the tank from imaging access port 304 .
  • FIG. 7 also shows how the housing 309 of station 300 may include an access port 706 to which vascular access system 302 can be attached, and which includes an additional port 718 into tank 306 , opposite to the port formed at the distal end 714 of the esophageal access system 700 .
  • Port 718 may be arranged to interface with a superior vena cava (SVC) interface on the patient-specific cartridge 308 , as described in further detail hereinafter.
  • SVC superior vena cava
  • the replicated esophageal access system/TEE approach system 700 may not be fully anatomical in terms of shape, size and angulation of a patient's esophagus 708 .
  • a standardized approach for the TEE approach system 700 may be used that allows a clinician to place a TEE probe 505 in a position in the station 300 that corresponds to the position a TEE probe would be positioned during an actual procedure, with similar, though not fully simulated tactile feedback provided to the clinician.
  • FIG. 8 illustrates station 300 , in side-view alignment with, and superimposed on a representation of a generic patient's esophagus 708 , showing how the imaging access port 304 is generally aligned with the generic patient's mouth 800 , and pipe sections 702 and 704 approximate the pathway of the generic patient's esophagus 708 and lead to the bottom of tank 306 at a position that would be beneath the patient's heart 802 .
  • the simulated esophageal access system 700 of FIG. 7 may provide good ergonomics without leaks and without impacting the realism of the navigation of the imaging device.
  • FIGS. 9 and 10 show certain design parameters selected for the esophageal access system 700 that provide the realistic navigation with improved ergonomics.
  • Such parameters include first and second bends 904 and 906 having radii of curvature (e.g., 67 mm) at the respective proximal and distal ends of the replicated esophageal channel 900 , the length of a conduit 903 between the proximal and distal bends (e.g., 125 mm), and the angle formed between the conduit 903 and the bottom of the tank in the station (e.g., 150 degrees).
  • FIGS. 9 and 10 portions of the fluid flow control system 909 of station 300 are also shown, as will be described in further detail hereinafter.
  • FIG. 11 shows another view of the esophageal access system 700 in the station 300 , with a cartridge 308 installed in the tank 306 and coupled, at interface port 718 , to vascular access port 706 within the housing.
  • FIG. 12 shows a cross section of the primary conduit 903 of the replicated esophageal channel 900 with illustrative, non-limiting dimensions.
  • the esophageal access system 700 may include first and second pipe sections 702 and 704 within the housing 309 , the first pipe section 702 extending from the esophageal access port 304 on the housing 309 to the second pipe section 704 , and the second pipe section 704 extending from the first pipe section 702 to a first port (at distal end 714 ) in the tank 306 .
  • the first pipe section 702 may include a first bend 904 at a proximal end, and a substantially straight conduit 903 extending from the first bend 904 to the second pipe section 704 .
  • the second pipe section 704 includes a second bend 906 .
  • the second bend 906 may form an angle of between one hundred thirty degrees and one hundred seventy degrees between the substantially straight conduit 903 and a bottom surface (see, e.g., bottom surface 1402 of FIG. 14 ) of the tank.
  • the esophageal access system 700 may also include a first membrane 711 at the esophageal access port 304 and a second membrane 712 at an interface between the first pipe section 702 and the second pipe section 704 .
  • esophageal access system 700 may combine two interchangeable membranes (e.g., latex membranes) located on the way to the tank 306 (e.g., a proximal membrane 711 at the top of the station 300 at the proximal end of the esophageal access system 700 , and a distal membrane 712 just before the tank), as illustrated in FIG. 13 . These two membranes 711 and 712 may be changed easily in order to be compatible with all probes (e.g., different brands, shrinking sizes, etc.)
  • FIG. 14 shows a top-down view of the station tank 306 , with the patient-specific cardiac model removed.
  • a recess 1400 is formed in the bottom surface 1402 of tank 306 , into which the TEE probe can extend from the tank port at the distal end 714 of the esophageal access system 700 .
  • the recess 1400 is wider than the probe 505 allowing the clinician an ability to adjust the probe position within the tank 306 in a realistic manner with realistic movement constraints.
  • FIG. 14 also shows how access port 718 may be formed on a sidewall 1491 of tank 306 .
  • additional access ports such as access ports 1404 and 1408 can be provided on an opposing sidewall 1489 of tank 306 .
  • Access port 718 may be arranged to interface with a simulated superior vena cava interface on patient-specific cartridge 308 .
  • Access port 1404 may be arranged to interface with a simulated inferior vena cava interface on patient-specific cartridge 308 .
  • Access port 1408 may be arranged to interface with a simulated upper pulmonary vein interface on patient-specific cartridge 308 .
  • FIG. 14 also shows how one or more fluidic openings such as fluidic openings 1406 , 1410 , and 1412 may be provided in tank 306 , to allow flow of blood simulation fluid 307 around a patient-specific cartridge 308 that is mounted in tank 306 (e.g., in addition to and/or in place of fluid 307 flow into and/or out of the patient-specific structures of cartridge 308 via access ports 1404 , 1408 , and 718 ).
  • Fluidic openings 1406 , 1410 , and 1412 may be fluidically coupled to fluid control system 909 (see, e.g., FIGS. 9 and 10 ), as described in further detail hereinafter, and may be located at different positions from those shown in FIG. 14 in some implementations.
  • Access ports 1404 , 1408 , and 718 may also, or alternatively, be fluidically coupled to fluid control system 909 (see, e.g., FIGS. 9 and 10 ), as described in further detail hereinafter.
  • FIGS. 15A and 15B show perspective exploded and perspective views, respectively, of the vascular access system 302 that couples to and extends away from the station 300 .
  • the vascular access system 302 replicates the anatomic and certain biomechanical features of the vascular pathway from the right femoral vein to the inferior vena cava that a clinician would experience in a live procedure.
  • the proximal end 1500 (e.g., the end configured to be proximal to the clinician during a simulated procedure) of the vascular access system 302 includes sealing membrane 1502 (e.g., a latex seal) that can be punctured by a catheter to simulate the introduction of a catheter into the right femoral vein of a patient (e.g., into the femoral vein and through the skin).
  • sealing membrane 1502 e.g., a latex seal
  • the vascular access port 310 formed at proximal end 1500 is wide enough to allow for the use of an introducer, which may be needed for certain difficult to catheterize patients.
  • the sealing membrane 1502 is replaceable by removal of a seal cap 1504 that covers the proximal end 1500 of the vascular access system 302 .
  • the sealing membrane 1502 itself can include several alignment holes 1506 that are aligned with posts 1508 extending upwards from a portion of the proximal end of the vascular access system to ensure proper seal placement.
  • the bottom side of the vascular access system 302 includes a number of flanges 1517 extending downwards from the main shaft 1510 to support the vasculature access system at a height over a Cath lab patient table (see, e.g., table 210 of FIG. 2 ) that would be anatomically appropriate for an average patient.
  • a Cath lab patient table see, e.g., table 210 of FIG. 2
  • the vascular access system 302 can be constructed of multiple components joined together.
  • the assembly is in some implementations semi-rigid to improve the stability of the device on a work surface (such as a Cath lab table), to reduce the likelihood of cantilevering of the device, and improve durability of the device.
  • the main shaft 1510 includes an interior lumen (not visible in FIGS. 15A and 15B ) of the vascular access system 302 , which can have a substantially constant diameter for the majority, or in some implementations, the entirety of the length of the lumen.
  • FIGS. 16A and 16B show a side view and top view, respectively, of the vascular access system 302 .
  • the vascular access system 302 e.g., the main shaft 1510 and internal lumen
  • has a curvature e.g., including a first or proximal curve 1611 and a second or distal curve 1613 ) that substantially replicates the path of the right femoral vein, iliac vein and inferior vena cava to the right atrium.
  • FIG. 17 shows a top down cutaway view of the vascular access system 302 coupled to the housing 309 of the station 300 at access port 706 .
  • the access system 302 can be screwed onto the access port 706 of the housing 309 , providing fluidic access between the internal lumen 1700 within main shaft 1510 to the interior of the tank 306 .
  • the coupling between vascular access system 302 and access port 706 of housing 309 provides fluidic coupling between internal lumen 1700 and a portion of the patient-specific model that simulates a portion of the right atrium of the patient.
  • FIG. 18 shows an enlarged view of the access port 706 , formed in the housing 309 , for connection between the vascular access system 302 and a cartridge 308 installed in the tank 306 of the station 300 .
  • the access port 706 may be implemented as a dual-lumen pipe 1800 within housing 309 , with a central lumen 1805 allowing a catheter access to a cardiac model within the station tank 306 and to allow fluid to flow into the vascular access system 302 (e.g., into main lumen 1700 ).
  • An outer toroidal chamber 1802 may be provided that surrounds the central lumen 1805 and is fluidically coupled to the central lumen 1805 through an array of through holes 1804 .
  • the holes 1804 may be angled away from the tank 306 of station 300 at, for example, 60 degrees from the horizontal, though the angle can be between 50 and 75 degrees in other implementations. This angling of the holes 1804 away from tank 306 (e.g., opposite to the direction in which surgical instruments moved toward the tank during insertion) helps ensure that a catheter, guidewire, or other surgical instrument being inserted into the tank via central lumen 1805 does not catch on the holes.
  • the holes 1804 in the illustrated implementation, have a diameter of 1.5 mm, but can range from 1.0-2.0 mm in other implementations.
  • the toroidal chamber 1802 is fluidically coupled by a return fluid channel 1702 to the tank 306 .
  • the hole array only occupies the top half of the wall of the central lumen 1805 . In other implementations, more or less of the wall surface of the central lumen 1805 is occupied by through holes.
  • FIGS. 20 and 21 show two different perspective views of the housing 309 of station 300 , showing the tank 306 at different angles. Also seen in FIGS. 20 and 21 is an opening 2002 in housing 309 for the proximal end 710 of the esophageal access system 700 .
  • FIG. 20 shows interface port 718 connecting to the passageway (e.g., central lumen 1805 of access port 706 ) out of the tank 306 to the vascular access system 302 .
  • the passageway e.g., central lumen 1805 of access port 706
  • the interior of the tank 306 may be coated with acoustic shielding 2006 .
  • a perspective view of the acoustic shielding 2006 is also shown in FIG. 22 .
  • the acoustic shielding 2006 may be constructed from ethylene propylene diene monomer (EDPM) rubber, though other polymer coatings with similar acoustic properties could be used instead.
  • EDPM ethylene propylene diene monomer
  • the acoustic shield 2006 helps prevent the walls of the tank 306 from impacting the ultrasound images (i.e., by reducing acoustic noise) obtained via the TEE probe.
  • Acoustic output measurements or ultrasonic imaging/testing in general can be strongly affected by reflections or echoes from test tank walls.
  • the tank 306 may be coated with linings of low ultrasonic reflection yet highly absorbent to ultrasound (EDPM is one such material).
  • acoustic shielding 2006 may provide absorption of acoustic energy in the frequency range of 1 MHz ⁇ F ⁇ 10 MHz (e.g., the frequency range for medical ultrasound imaging), or 4 MHz ⁇ F ⁇ 8 MHz (e.g., the frequency range for TEE: Trans Esophageal Echography).
  • FIG. 23 shows two ultrasound images, including a first image 2300 obtained with a tank that has the acoustic shielding 2006 , and a second image 2302 obtained with a tank that does not have acoustic shielding, to show the impact of the shielding.
  • FIG. 24 shows a cutaway view of the tank 306 with the acoustic shielding 2006 . Also visible in FIG. 24 are the distal end 714 of the esophageal access system 700 , the recess 1400 in which a TEE probe can positioned after passing through lumen 900 , the access port 706 for coupling to the vascular access system 302 , and a fluid channel 2402 for introducing fluid into the simulated pulmonary vein of the cardiac model (not shown in FIG. 24 ). As shown, the recess 1400 may be a recess in a bottom wall 2400 of tank 306 .
  • the presently disclosed systems and methods utilize a patient-specific cartridge 308 with a patient-specific cardiac model that has the advantages of being arranged for mounting to interface port 718 in tank 306 of station 300 , and of being multi-material.
  • the cardiac model may be derived directly from a patient-specific anatomy into a biomechanical simplified model, approaching the biomechanical behavior of the anisotropic vascular wall material and as well as being, in some implementations, visible under echography.
  • FIG. 25 illustrates an example of a patients-specific cartridge 308 that includes a frame 2500 and a cardiac model 2502 .
  • the cardiac model 2502 one or more, and in some implementations, all of the following components are patient specific: the replicated septum 112 ′, the replicated fossa ovalis 400 ′ of the septum (e.g., both the position and biomechanics of the replicated fossa ovalis 400 ′ may be patient specific for tenting and puncture), a replicated upper 2.5 cm-5 cm (e.g., 3 cm) of the replicated left pulmonary vein 2505 and the spur (also referred to as a ridge) separating the left pulmonary vein 2505 from the left atrium 2504 , the replicated Left Atrial Appendage 116 ′ (e.g., the position of the LAA 116 and its trabeculae, including both position and biomechanics can be patient specific), and the replicated mitral ring 2503 (e.g., the position of the replicate
  • the cardiac model 2502 may include either patient-specific or standardized portions for a replicated portion 2506 of the right atrium and non-patient specific portions of the left atrium 2504 .
  • a method for fabricating a patient-specific physical cardiac simulation device such as patient-specific cartridge 308 may include segmenting the region of interest from typical medical imaging modalities such as MRI, CT; creating a 3D geometric model from the segmented images, integrating the 3D geometric model to a standard (patient-independent) frame, creating a 3D Finite Element model of the anatomical region of interest, assigning realistic material properties from a data-bases of biomechanical cardiovascular tissue model, creating a second 3D Finite Element model, applying a goal-based design optimization algorithm to the second 3D Finite Element model to assign the distribution of printable materials that can replicate the behavior of the first 3D Finite Element model, and printing (e.g., using additive manufacturing techniques) the multi-material model with the frame. More detailed descriptions of this process can be found in PCT Applications WO/2018/050915 and WO/2018/051162, each of which is hereby incorporated by reference in its entirety.
  • the frame 2500 holds a cardiac model 2502 that includes a portion 2506 corresponding to a patient's right atrium, a portion 2504 corresponding to the patient's left atrium, a portion 116 ′ corresponding to the patient's left atrial appendage 116 extending off from the left atrium that has the shape and biomechanics of the left atrial appendage of the patient, and a portion corresponding to the patient's pulmonary vein 2505 (positioned behind the left atrial appendage).
  • a portion 400 ′ corresponding to the patient-specific fossa ovalis separates the right atrium from the left atrium.
  • the portion 2506 corresponding to the right atrium need not be patient specific and may have a standard shape and material composition.
  • FIGS. 26A and 26B illustrate perspective and top views, respectively, of another example cardiac model 2502 incorporated into a frame 2500 , according to another implementation.
  • the cardiac model 2502 shown in FIGS. 26A and 26B includes a window 2600 in an upper facing-portion of the replicated right atrium 2506 .
  • the window 2600 formed by an absence of material (for example), provides both visual access to the replicated right atrium 2506 during a planning/practice procedure, reduces the time, complexity, materials, and cost of manufacturing the cardiac model 2502 , as well as improves the ultrasound aspect of the device (e.g., by avoiding unrealistic ultrasound effects generated by a top wall of the right atrium).
  • the model 2502 shown in FIGS. 26A and 26B includes a replicated aortic valve annulus 2602 not seen in FIG. 25 .
  • the replicated fossa ovalis 400 ′ can be seen clearly through the window 2600 formed in the right atrium model portion 2506 , avoiding the need for fluoroscopy during the practice/planning procedure.
  • the window 2600 provides an avenue for air bubbles to escape the replicated right atrium 2506 that might introduce artifacts in an ultrasound image.
  • the frame 2500 in all of FIGS. 25, 26A, and 26B is shaped such that it curves around the anatomic structures relevant to the procedure to avoid introduction of ultrasound artifacts, while still supporting (but not over-supporting) the cardiac model 2502 .
  • the frame 2500 also has standard dimensions used for all patients, so that the cartridge 308 can be securely positioned within the tank 306 of the station 300 and such that the fluidic channels of fluid control system 909 of the station mate with the model fluid ports connected to the right atrium and pulmonary vein portions 2506 and 2505 of the model 2502 to ensure proper fluid flow through the model. For example, as shown in FIG.
  • frame 2500 may include openings 2609 , 2611 , and 2613 corresponding, respectively, to the simulated superior vena cava interface, the inferior vena cava interface, and the upper pulmonary vein interface of the patient-specific model 2502 , and respectively, to the access ports 718 , 1404 , and 1408 in tank 306 .
  • the standard frame 2500 includes the right atrium portion 2506 of the cardiac model 2502 , other than the septum 112 ′ and fossa ovalis 400 ′ separating the right atrium from the left atrium portions of the model.
  • the artificial tissues may range in thickness from between about 0.5 cm to about 2.5 cm.
  • FIG. 27 shows two images 2700 A and 2700 B, each with a view of an example model fossa ovalis 400 ′, included in the cardiac model 2502 .
  • Image 2700 A shows a view of the external surface 2702 of the model fossa ovalis 400 ′.
  • Image 2700 B shows a view of the interior structure of the model fossa ovalis 400 ′.
  • the model fossa ovalis 400 ′ can be constructed from, for example, three structural layers, including two outer layers (e.g., one facing the right atrium and one facing the left atrium), and an inner reinforced layer 2707 .
  • the inner reinforced layer 2707 includes an array of honeycomb structures.
  • the thickness and other material and/or mechanical properties of the patient-specific model 2502 may be selected and arranged to provide both a patient-specific flexible septum, and a patient-specific flexible fossa ovalis. More specifically, the flexibility of various portions of patient-specific model 2502 is based on both the shape of the anatomy of the specific patient, and on the mechanical properties of the whole septum structure. As would be understood by one of ordinary skill in the art, the fossa ovalis is a portion of the septum, being defined as an oval/round depression in the lower posterior part of the interatrial septum (e.g., in average 30% of the whole septum area), composed primarily by thin fibrous tissue.
  • the simulated fossa ovalis may be provided with a superior-inferior diameter of, for example, 20.8 ⁇ 6.2 mm, an anterior-posterior diameter of, for example, 15.7 ⁇ 6.2 mm and thickness equal to, for example, 0.68 ⁇ 0.27 mm, the lowest in the whole septum anatomy. Then, moving anteriorly or posteriorly the thickness may increase, with an average value of about, for example, 1.8 ⁇ 0.7 mm.
  • the simulated septum 112 ′ may be thickest above the fossa ovalis 400 ′ adjacent to superior vena cava entrance 2609 (e.g., 3.4 mm in average); e.g., 1.8 mm thick, in average, in the narrow isthmus anterior to the fossa and in the most inferior portion; e.g., 2.4 mm, in average, in the area immediately inferior to the fossa.
  • superior vena cava entrance 2609 e.g., 3.4 mm in average
  • 1.8 mm thick in average, in the narrow isthmus anterior to the fossa and in the most inferior portion
  • e.g., 2.4 mm in average, in the area immediately inferior to the fossa.
  • the thickness and the material properties of the simulated septum may be arranged to create a gradient zone moving from the outer part of the septum towards the center (fossa ovalis), progressively increasing (e.g., in a direction opposite the radial direction R indicated in FIG. 27 ) the flexibility and the compliance of the model wall, by the arrangement of the materials and/or thicknesses of the model at those locations.
  • the thickness and the material properties the simulated left atrium tissue may be selected based on the strain energy function in Equation 1 below:
  • I 1 and I 2 are invariants of strain
  • c ij are material constants such as the constants provided in Table 1 below.
  • the mechanical features of the simulated septum 112 ′ are arranged to mimic biological soft tissue, particularly with respect to the interatrial septum fibers, which have a hierarchical microstructure that results in hyperelastic properties. These mechanical features of the simulated septum 112 ′ allow the patient-specific cartridge 308 to mimic a patient's actual transseptal tenting and puncture for clinicians training and/or patient-specific rehearsal.
  • the mechanical features of the simulated septum 112 ′ may be arranged to be nearly isotropic and hyperelastic. Accordingly, in some implementations, the simulated fossa ovalis 400 ′ of patient-specific model 2502 may be isotropic and hyperelastic with a flexibility gradient of decreasing flexibility with increasing radial distance from the center of the fossa ovalis.
  • FIG. 27 also includes a diagram 2700 C showing more detailed geometry of the honeycombs 2709 that may be included in inner reinforced layer 2707 , and that may be arranged (e.g., along with the thickness and material properties of the surrounding layers) to provide the patient-specific flexibility and tenting characteristics of the simulated septum 112 ′ and fossa ovalis 400 ′ of the patient-specific model.
  • each honeycomb 2709 can be hexagonal in shape, with a diameter D ranging from around 5.0 mm to about 6.0 mm.
  • the honeycomb can be fabricated, for example, from Acrylonitrile butadiene styrene (ABS).
  • the distance (d) between cells can range from about 0.4 to about 0.5 mm.
  • the out-of-plane thickness of the honeycomb (which corresponds to the thickness of the entire inner layer) is about 0.3 to about 0.4 (e.g., 0.36) mm.
  • the honeycomb structure can be filled, for example with Agilus polyjet material having a Young's Modulus of between about 0.6-5 MPa.
  • the ABS that forms the honeycomb can have a Young's Modulus of between about 1-2 GPa.
  • the inner and outer layers of the model fossa ovalis 400 ′ can also be formed form Agilus, and have a thickness of between about 0.30 mm and 0.35 mm (e.g., 0.32). Together the model fossa ovalis 400 ′ may be about 1 mm thick, though thickness may be varied based on the specific anatomy of the patient.
  • the remaining patient-specific portions of the cardiac model 2502 can be made from a combination of materials determined using the above-referenced optimization process (discussed further in PCT Applications WO/2018/050915 and WO/2018/051162) to obtain tissues that have shapes and biomechanical characteristics substantially similar to that of the actual patient's anatomy. Typical replicated anatomical wall thicknesses range from about 0.5 to about 2.5 cm. In some implementations, as described further in U.S. patent application Ser. No. 16/417,151, hereby incorporated herein by reference in its entirety, the materials can further be selected to achieve an ultrasound aspect that is substantially similar to that of the actual specific patient.
  • manufacturing the patient-specific portions of patient-specific model 2502 may include obtaining medical image data of an organ (e.g., the patient's heart) within a specific patient.
  • the medical image data may then be processed to generate one or more data files including a volumetric model of the organ.
  • Generating the data file(s) may include receiving one or more material data files specifying a configuration of one or more materials to be deposited by an additive manufacturing system.
  • the patient-specific model may then be generated by dispensing at least one first material having lower acoustic impedance properties and a second material having higher acoustic impedance properties.
  • the medical image data of the organ may be obtained using common medical imaging modalities such as X-ray radiography, X-ray rotational angiography, MRI, CT scanning, ultrasound imaging (2D or 3D), or nuclear medicine functional imaging techniques such as positron emission tomography and single-photon emission computed tomography.
  • the medical image data may be obtained for an organ within a specific patient or for part of a larger organ.
  • the organ may be a heart, a portion of a heart, or an artery.
  • the medical image data may also include data associated with organs surrounding or located in close proximity to the organ being imaged such as bones, joints, fatty tissue, glands, or membranes which may exert mechanical feedback on the organ to be replicated.
  • the medical image data may be processed to generate a volumetric model of the specific organ to be replicated as the patient-specific model 2502 .
  • the volumetric model may be generated by converting the medical image data into a three dimensional data model describing the anatomic characteristics of the organ to be replicated.
  • the anatomic characteristics may include various linear dimensions, volume dimensions, thicknesses, as well as other characteristics of the organ being replicated, such as tissue echogenicity.
  • Such characteristics can be derived directly from the medical imaging data collected (e.g., from ultrasound images), or indirectly by reference to one or more databases or other electronic data sources of anatomical knowledge that stores reference information about representative tissue characteristics of various tissues in the body.
  • the volumetric model includes a three dimensional set of nodes which define a plurality of elementary volumetric elements or voxels partitioning a space region (e.g., the space encompassed by the organ or portions of the organ) modeled by the volumetric model.
  • the elementary volumetric elements may be defined as shapes of a tetrahedron, a pyramid, a triangular prism, a hexahedron, a sphere, or an ovoid.
  • the volumetric model may be generated from a three dimensional surface mesh of the organ to be replicated which captured in the medical image data. In some implementations, the volumetric model may be generated by performing volumetric model generation on the surface mesh.
  • the volumetric model is generated by performing finite-element volumetric model generation on the medical image data.
  • the volumetric model is further processed to generate a deformed volumetric model of the organ to be replicated.
  • the deformed volumetric model replicates the loads and constraints imposed on the in vivo organ tissue of a specific patient by one or more organ tissues surrounding the specific patient's in vivo organ tissue.
  • the assigned materials may include materials of differing acoustic impedance values, such as higher acoustic impedance materials, lower acoustic impedance material, or mixtures or suspensions of materials having different acoustic impedances.
  • Material assignment is performed using a cost function to minimize the error between the desired echogenic properties (determined based on the medical image data or from electronic databases or data sources storing representative tissue characteristic data) and the resulting echogenic properties of the combination of one or more of the materials selected for deposition in a location corresponding to a given voxel or cluster of voxels of the volumetric model.
  • the cost function may include additional cost functions, for example a cost function to minimize the error associated with the elastic material properties or other mechanical material properties of the organ being replicated.
  • material assignment may be achieved by solving the cost function using a joint search to minimize the sum of the errors between the mechanical material properties and the echogenicity material properties.
  • weights may be applied to the respective constituent cost functions based on the desired application. For example, it may be desirable to apply a higher weight to the cost function associated with mechanical material properties when accurately simulating echogenicity in the patient-specific model 2502 is less important. Alternatively, it may be important to weight the cost function associated with echogenic material properties higher in situations where it is critical to accurately simulate echogenicity in the patient-specific model 2502 . After performing a joint search as described above, a final volumetric model may be generated.
  • a predetermined number of best fitting echogenic (acoustic) property models could be evaluated using a mechanical property cost function to select an overall best fitting model. Additionally, or alternatively, a predetermined number of best fitting mechanical property models may be evaluated using an echogenicity cost function to identify an overall best fitting model.
  • the cost function may include constraints to prevent aspects of the volumetric model from being assigned specific materials. For example, a constraint may be implemented to require lower acoustic impedance materials formed from sacrificial material to be fully encapsulated within one or more higher acoustic impedance materials.
  • the object materials to be assigned to each voxel that were determined as a result of applying the cost function(s) may be selected from a database of object materials.
  • a particular material may be selected based on the results of minimizing a cost function for a given region (e.g., a cluster) or plurality of elementary volumetric elements of the volumetric model.
  • processing the medical image data includes converting the medical image data from a data or file format that is specific to the particular medical imaging modality used to obtain the medical image data into a data or file format that is compatible with an additive manufacturing system.
  • the medical image data may be processed and converted into one or more STL data files or other additive manufacturing system compatible file format.
  • the STL file format may be utilized by the additive manufacturing system to generate a 3D patient-specific model 2502 based on the volumetric model included in the one or more data files.
  • One or more material data files may specify a configuration of one or more materials to be deposited by an additive manufacturing system.
  • the one or more material data files may define an arrangement or configuration of a plurality of echogenic and non-echogenic materials (or higher acoustic impedance and lower acoustic impedance materials) to be deposited by the additive manufacturing system based on the processed image data. For example, based on the plurality of materials assigned to each voxel of the volumetric model included in the one or more material data files, the additive manufacturing system may determine the arrangement of one or more materials to be deposited in one or more layers to form the patient-specific model 2502 .
  • the additive manufacturing system may form the patient-specific model 2502 by dispensing at least one material having lower acoustic impedance properties and a second material having higher acoustic impedance properties.
  • the additive manufacturing system dispenses the plurality of materials to form the patient-specific model 2502 .
  • the plurality of materials includes at least one lower acoustic impedance material and a higher acoustic impedance material.
  • the two materials may be dispensed simultaneously as a suspension of the higher acoustic impedance material within the lower acoustic impedance material, or as separate depositions of higher acoustic impedance material and lower acoustic impedance materials.
  • the additive manufacturing system dispenses the appropriate material determined for a given elementary volumetric element defined in the volumetric model of the organ to be replicated. For example, the additive manufacturing system dispenses amounts of at least one hypo-echogenic material at locations in the patient-specific model 2502 which map or correspond to the same locations in the volumetric model that were determined to be less echogenic areas or regions based on the medical image data.
  • hyper-echogenic materials e.g., a suspension with a higher density of high acoustic impedance material
  • a voxel is a logical construct which can be processed by an additive manufacturing device to determine an appropriate set of independent material depositions.
  • some volumetric models may be generated with lower resolution than a print-resolution of a 3D printer used to print the patient-specific model 2502 .
  • the 3D printer may make multiple deposits of material to generate a single voxel.
  • each voxel may correspond to a 3 ⁇ 3 ⁇ 3, 4 ⁇ 4 ⁇ 4, 5 ⁇ 5 ⁇ 5, or other sized cuboid of material depositions.
  • voxels may translate into ovoid or other shaped depositions, rather than cuboid depositions.
  • the 3D printer used to fabricate the patient-specific model 2502 may translate an echogencity value assigned to each voxel to an appropriate pattern of material depositions within a given a corresponding cuboid or ovoid deposition.
  • each voxel corresponds to a single material deposition, which may have a spherical, ovoid, rectangular or other regular or irregular shape depending on the equipment used to make the deposition.
  • the at least one material having lower acoustic impedance properties and the second material having higher acoustic impedance properties may be dispensed by the additive manufacturing system using casting, 3D printing, mechanical linkages of disparate materials and material deposition manufacturing.
  • a variety of additive manufacturing processes may be utilized by the additive manufacturing system to form the patient-specific model 2502 including binder jetting, directed energy deposition, material jetting, power bed fusion, fused deposition modeling, laser sintering, stereolithography, photopolymerization, and continuous liquid interface production.
  • 3D printers using PolyJet MatrixTM technology may be used to simultaneously dispense a plurality of materials having different elastic and acoustic impedance properties to form an patient-specific model 2502 with varying elastic and echogenic properties at one or more locations.
  • the at least one material having higher acoustic impedance properties includes a polymerized material, such as PolyJet material having a polymerized density of 1.18-1.21 g/cm 3 .
  • the lower acoustic impedance includes a hydrogel with acoustic properties similar to water.
  • the lower acoustic impedance material includes a non-polymerized material such as water, a gel, an ion, or a bio-molecule.
  • the patient-specific model 2502 includes a fossa ovalis 400 ′ having a flexibility corresponding to a flexibility of a fossa ovalis of the heart of the patient (e.g., a flexibility that decreases with increasing radial distance from a center thereof, such as according to the decreasing flexibility of the fossa ovalis of the patient with the same increasing radial distance).
  • FIG. 28 shows three images 2800 A, 2800 B, and 2800 C of an example cardiac model cartridge 308 under ultrasound, demonstrating the biomimetic ultrasound response of the model.
  • images 2800 A and 2800 B show the model septum before and after pressure from a puncturing instrument is applied to the septum (causing the tenting in image 2800 B).
  • Image 2800 C shows the model LAA before and after occlusion.
  • the surgical simulation device 202 may be used by providing a surgical simulation device 202 having a station 300 having a housing 309 , a tank 306 formed in the housing 309 , and a vascular access system 302 coupled to the housing 309 , providing, in the tank 306 , a patient-specific cartridge 308 that includes a patient-specific model 2502 of at least a portion of a heart of a patient, inserting an imaging device (e.g., TEE probe 505 ) through an esophageal access system 700 within the housing 309 from an esophageal access port 304 on the housing 309 , though a first port (at end 714 ) in the tank 306 , and into a recess 1400 in a bottom surface 1402 of the tank 306 beneath the patient-specific cartridge 308 , and inserting a surgical element (e.g., a guidewire, a tool, etc.) from a vascular access port 310 of the vascular access system 302 , through an imaging device
  • FIG. 29 shows an example entry to the replicated left atrial appendage 116 ′ to be occluded during example procedures contemplated to be carried out using the station 300 and cartridges 308 disclosed herein.
  • the interior surface 2900 of replicated left atrial appendage 116 ′ may include a micropattern of small depressions 2902 .
  • the depressions 2902 shown in FIG. 29 are circular in shape, though other regular or irregular geometric shapes may also be used.
  • Each depression 2902 can be between about 0.1 mm and 1.0 mm in diameter and be between 0.1 mm and 2.0 mm deep.
  • the micropattern improves the ability for atrial appendage occluders to anchor to the simulated tissue.
  • the micropattern may extend to from about 1.0 cm to about 2.5. cm into the model left atrial appendage 116 ′.
  • FIG. 30 illustrates a portion of a patient heart that can be modeled by a patient-specific model of a patient-specific cartridge of a physical simulator device, according to aspects of the disclosure.
  • FIG. 30 shows a patient's fossa ovalis 3000 , and various potential puncture locations thereon, relative to other cardiac structures such as the coronary sinus ostium (CS Os) 3002 , right atrium (RA), and inferior vena cava (IVC), and indicates the radial direction R′ of the patient's negative flexibility gradient, corresponding to the radial direction R of the flexibility gradient of the simulated fossa ovalis 400 ′ described above in connection with FIG. 27 .
  • CS Os coronary sinus ostium
  • RA right atrium
  • IVC inferior vena cava
  • patient-specific cartridge 308 may include a patient-specific model 2502 coupled to a frame 2500 .
  • the frame 2500 is a patient-independent frame that can carry various different patient-specific models.
  • FIG. 31 illustrates a perspective view of a patient-specific cartridge having a patient-independent frame, according to aspects of the disclosure. As shown in FIG.
  • patient-specific model 2502 may include a patient-specific portion (e.g., including the simulated right atrium 2506 , the simulated left atrium 2504 , the simulated aortic annulus 2602 , and the left atrial appendage 116 ′) in which the shape, mechanical properties, acoustic properties, and/or other properties correspond to the same properties of a specific patient.
  • the patient-specific model 2502 may also include interfacing portions such as interfacing portions 3100 , 3102 , and 3103 that may deviate, in shape, size, orientation, and/or mechanical properties, from the corresponding properties of the patient, in order to interface with standard frame 2500 . As shown in FIG.
  • patient-independent frame 2500 may include a base portion 3108 , a proximal portion 3112 , and a distal support 3110 surrounding opening 2609 (e.g., corresponding to a superior vena cava interface for patient-specific cartridge 308 ).
  • interfacing portion 3100 extends between the patient-specific portion of patient-specific model 2502 and opening 2609 of frame 2500 .
  • Interfacing portions 3100 , 3102 , and 3103 may be integrally formed portion of a contiguous patient-specific model 2502 , though they may deviate from the patient's anatomical shape.
  • FIG. 32 illustrates a perspective view of the patient-independent frame 2500 of FIG. 31 , with the patient-specific model removed.
  • proximal portion 3112 may include two additional openings 2611 and 2613 .
  • a curved support structure 3207 may also extend from proximal portion 3112 for supporting and/or orienting patient-specific model 2502 on the frame.
  • FIG. 33 illustrates a perspective view of a patient-specific cartridge 308 having a patient-specific model 2502 coupled to a patient-independent frame 2500 in an orientation in which an upper pulmonary vein interface portion 3102 of patient-specific model 2502 extends between the patient-specific portion of patient-specific model 2502 and opening 2613 in frame 2500 .
  • each patient-specific model 2502 is arranged to include features that anatomically, mechanically, and/or acoustically correspond to a particular patient, while coupling to the same patient-independent frame 2500 , which reduces cost, and increases ease of use of the simulator device 202 .
  • FIG. 34 illustrates a patient-specific cartridge 308 having another patient-specific model 2502 coupled to the patient-independent frame 2500 .
  • the patient-specific portion of patient-specific model 2502 is different from that of FIG. 33 , resulting in interfacing portions 3100 ′, 3102 ′, and 3103 ′ having different shapes from portions 3100 , 3102 , and 3103 of FIG. 33 that allow interfacing to the same standard openings 2609 , 2611 , and 2613 of the same standard model 2500 .
  • FIG. 35 illustrates a patient-specific model 2502 , emphasizing the patient-specific portion(s) of the model, which may include the simulated right atrium 2506 , aorta 2602 , left atrium 2504 , and left atrial appendage 116 ′.
  • FIG. 35 illustrates a patient-specific model 2502 , emphasizing the patient-specific portion(s) of the model, which may include the simulated right atrium 2506 , aorta 2602 , left atrium 2504 , and left atrial appendage 116 ′.
  • FIG. 35 illustrates a patient-specific model 2502 , emphasizing the patient-specific portion(s) of the model, which may include the simulated right atrium 2506 , aorta 2602 , left atrium 2504 , and left atrial appendage 116 ′.
  • FIG. 36 illustrates three different patient-specific models 2502 A, 2502 B, and 2502 C, each having different patient-specific features (e.g., patient-specific right atria 2506 , aortas 2602 , left atria 2504 , and left atrial appendages 116 ′) that match the anatomical, mechanical, and acoustic characteristics of the corresponding features of a particular patient, and each having different interfacing portions 3100 , 3102 , and 3103 that allow the different patient-specific features to interface with the same standard frame 2500 .
  • the three different patient-specific models 2502 A, 2502 B, and 2502 C can be coupled to a patient-independent frame 2500 to form three different patient-specific cartridges 308 A, 308 B, and 308 C.
  • FIG. 37 shows how a patient-specific model 2502 can have an integrally formed upper pulmonary vein interfacing (coupling) portion 3102 that deviates from the patient's anatomical form and extends between the patient-specific portion and opening 2613 .
  • Arrow 3700 indicates that the interfacing portion 3102 is a supplemental piece of the patient-specific model 2502 , though the patient-specific portion and the interfacing portion 3102 can be formed in a common manufacturing process (e.g., an additive manufacturing process).
  • a patient-specific cartridge 308 for a surgical simulator device 202 may include a patient-independent frame 2500 (sometimes referred to herein as a standard frame) having first, second, and third openings 2609 , 2611 , and 2613 , and a patient-specific cardiac model 2502 .
  • the patient-specific cardiac model 2502 may include a right atrium 2506 , a left atrium 2504 and a septum 112 ′ having mechanical and anatomical shape properties that correspond to the mechanical and anatomical shape properties of the left atrium 102 and the septum 112 of a patient, a superior vena cava interfacing portion 3100 that deviates from the anatomical shape of the superior vena cava of the patient and extends between the right atrium 2506 and the first opening 2609 in the patient-independent frame 2500 ; an inferior vena cava interfacing portion 3103 that deviates from the anatomical shape of the inferior vena cava of the patient and extends between the right atrium 2506 and the second opening 2611 in the patient-independent frame 2500 , and an upper pulmonary vein interfacing portion 3102 that deviates from the anatomical shape of the pulmonary vein of the patient and extends between the left atrium 2504 and the third opening 2613 in the patient-independent frame 2500 .
  • FIGS. 38A and 38B respectively illustrate misaligned patient-specific superior vena cava and inferior vena cava interfacing portions 3802 and 3800 that do not align with standard frame 2500 , and corresponding interfacing portions 3100 and 3102 of a patient-specific model that deviate from the patient-specific forms of 3802 and 3800 to couple to openings 2609 and 2611 of a patient-independent frame 2500 .
  • FIG. 38A and 38B respectively illustrate misaligned patient-specific superior vena cava and inferior vena cava interfacing portions 3802 and 3800 that do not align with standard frame 2500 , and corresponding interfacing portions 3100 and 3102 of a patient-specific model that deviate from the patient-specific forms of 3802 and 3800 to couple to openings 2609 and 2611 of a patient-independent frame 2500 .
  • FIG. 38A and 38B respectively illustrate misaligned patient-specific superior vena cava and inferior vena cava interfacing portions 3802 and 3800 that do not align
  • 39 illustrates another view of the misaligned patient-specific superior vena cava and inferior vena cava interfacing portions 3802 and 3800 (which would not be manufactured), the corresponding interfacing portions 3100 and 3102 coupled to openings 2609 and 2611 , and an additional portion 3900 of the model that can be removed after manufacturing or omitted from manufacturing, to form an opening 2600 into the right atrium of the model.
  • FIG. 40 illustrates various aspects of a process for manufacturing a patient-specific cardiac model 2502 for coupling to a patient-independent (standard) frame 2500 , according to aspects of the disclosure.
  • the virtual patient-specific model may include patient-specific superior vena cava portion 3802 , patient-specific inferior vena cava portion 3800 , and patient-specific upper pulmonary vein portion 4003 , which would be misaligned with openings 2609 , 2611 , and 2613 of standard frame 2500 .
  • patient-specific features can be generated based on images and/or other measurements of the size, shape, orientation, thicknesses, and/or other properties of the patient's actual cardiac structures. As shown, three interfaces between the virtual patient-specific model and three planes 4000 , 4002 , and 4004 may be identified. Portions 3800 , 3802 , and 4003 extending beyond respective planes 4000 , 4002 , and 4004 may be removed, and interfacing portions 3011 , 3102 , and 3103 can be designed to extend between the identified planar interfaces and the known locations of standard frame openings 2609 , 2611 , and 2613 . Once these interfacing portions 3011 , 3102 , and 3103 are designed into the virtual model, the entire patient-specific model including these portions can be generated (e.g., in an additive manufacturing, molding, or other suitable manufacturing process).
  • the patient-specific cartridge 308 can be provided with a frame 2500 configured to couple the patient-specific model 2502 to the tank 306 .
  • the frame 2500 can include first, second, and third openings 2609 , 2611 , and 2613 configured to align with first, second, and third access ports 718 , 1404 , and 1408 in the tank.
  • the patient-specific model 2502 may include a patient-specific portion that corresponds to the anatomical shape of the corresponding portion of the heart of the patient, and first, second, and third interfacing portions 3100 , 3103 , and 3102 that deviate from the anatomical shape of the corresponding portions of the patient's heart to extend between the patient-specific portion and the first, second, and third openings 2609 , 2611 , and 2613 .
  • the first, second, and third interfacing portions 3100 , 3103 , and 3102 may correspond, respectively, to a superior vena cava interfacing portion, an inferior vena cava interfacing portion, and an upper pulmonary vein interfacing portion of the patient-specific model.
  • the patient-specific model 2502 may include a simulated right atrium 2506 having a window 2600 .
  • a patient-specific model 2502 with acoustic features that mimic the acoustic features of the corresponding patient cardiac structures (e.g., for ultrasound imaging during a simulated surgical procedure).
  • FIG. 41 illustrates, for example, a fluoroscopic image of an LAA closure device 502 being installed within a patient's heart, in which the shadow 4102 of the patient's heart and a shadow 4104 of the patient's spine can be seen. These shadows, while faint, can be helpful to a surgeon, in addition to ultrasound imaging with ultrasound probe 505 .
  • FIG. 41 illustrates, for example, a fluoroscopic image of an LAA closure device 502 being installed within a patient's heart, in which the shadow 4102 of the patient's heart and a shadow 4104 of the patient's spine can be seen. These shadows, while faint, can be helpful to a surgeon, in addition to ultrasound imaging with ultrasound probe 505 .
  • FIG. 41 illustrates, for example, a fluoroscopic image of an LAA closure device 502 being installed within a patient's heart, in which the shadow 4102 of the patient's heart and a shadow 4104 of the patient's spine can be seen. These shadows, while faint, can be helpful to a
  • patient-specific model 2502 and/or other portions of station 300 are provided with x-ray interactive features, while the ultrasound probe 505 , and a guidewire 507 can be seen in a fluoroscopic image 4200 of device 202 , image 4200 does not include the shadows 4102 and 4104 .
  • patient-specific model 2502 and/or portions of station 300 can be provided with x-ray interactive features.
  • FIG. 43 illustrates a cross-sectional view of a portion of a wall of a patient-specific model 2502 of a patient's heart.
  • the walls of patient-specific model 2502 may be formed (e.g., in a three-dimensional printing process) from an inner polymer (e.g., PolyJet) layer 4302 , an outer polymer (e.g., PolyJet) layer 4300 , and a hydrogel layer 4303 interposed between the inner and outer layers 4302 and 4300 .
  • inner layer 4302 and outer layer 4300 may be formed from Polyjet materials (e.g., Stratasys resins) that encapsulate hydrogel layer 4303 .
  • hydrogel layer 4303 may be used as a sacrificial support material or may be used to absorb an injected aqueous liquid such as an x-ray attenuating liquid.
  • Layers 4300 , 4302 , and/or 4303 may be arranged to mechanically and/or acoustically mimic the anatomical features of patient cardiac structures.
  • the patient-specific model 2502 may be provided with x-ray interactive material.
  • patient-specific model 2502 may be provided with an x-ray interactive coating 4400 (e.g., an x-ray attenuating coating such as an iodine coating, a barium coating such as a barium sulfate paint, a calcium phosphate coating, a radio opaque ink, a metal coating, a hydrophilic coating, and/or any combination thereof) on outer polymer layer 4300 (and/or on inner layer 4302 ).
  • an x-ray interactive coating 4400 e.g., an x-ray attenuating coating such as an iodine coating, a barium coating such as a barium sulfate paint, a calcium phosphate coating, a radio opaque ink, a metal coating, a hydrophilic coating, and/or any combination thereof
  • hydrogel layer 4303 may be injected with an x-ray interactive material (e.g., a contrast liquid including calcium, iodine, and/or barium such as Iohexol).
  • a contrast liquid including calcium, iodine, and/or barium such as Iohexol e.g., calcium, iodine, and/or barium such as Iohexol.
  • FIG. 45 illustrates a process for injecting an x-ray reactive material such as an x-ray attenuating material into a wall of a patient-specific model of a patient's heart, according to aspects of the disclosure.
  • layer 4303 may be injected with an x-ray attenuating aqueous liquid to form an x-ray attenuating internal layer 4502 for patient-specific model 2502 .
  • the injected X-ray attenuating aqueous liquid may diffuse inside the hydrogel layer 4303 to obtain a homogenous X-ray absorption characteristic all over the model 2502 to reproduce the heart shadow described above in connection with FIG. 41 .
  • Coating and/or injection of x-ray attenuating materials for patient-specific model 2502 can be performed during a post-processing of the model (e.g., following an additive manufacturing process to generate the model).
  • the patient-specific model 2502 includes at least one wall portion having an outer layer 4300 , an inner layer 4302 , and an x-ray attenuating material 4502 interposed between the outer layer and the inner layer.
  • FIGS. 44 and/or 45 may provide patient-specific cartridge 308 with fluoroscopic features that cause the patient-specific model 2502 to generate a cardiac shadow similar to cardiac shadow 4102 of FIG. 41 , under x-ray imaging of station 300 and cartridge 308 installed therein.
  • FIG. 46 illustrates a perspective view of a spinal shadow card 4600 that can be provided in station 300 to generate, under x-ray imaging, a spinal shadow similar to spinal shadow 4104 of FIG. 41 , according to aspects of the disclosure.
  • the shadow of the spine is used during the procedure by the clinician to estimate where the catheter is inside the right atrium. By knowing over which vertebra the catheter is, the surgeon is able to understand whether they are in front of the septum to initiate a transseptal puncture, for example.
  • spinal shadow card 4600 may include a substrate 4602 and a spinal simulation feature 4604 formed on the substrate.
  • Spinal simulation feature 4604 may be printed on, embedded within, etched in, or otherwise formed on or in substrate 4602 .
  • spinal simulation feature 4604 may be a radio opaque ink printed on an x-ray transparent substrate 4602 .
  • Spinal simulation feature 4604 may be patient-specific or may represent the geometrical shape of a shadow of a generic patient (e.g., to a C-ARM fluoroscopy instrument at least at 0 degrees during the catheter navigation in the right atrium).
  • FIG. 47 illustrates a side view of a station 300 of a physical simulator device 202 showing how a spinal shadow card 4600 may be disposed within the station beneath bottom wall 4700 of tank 306 .
  • a spinal simulation card is disposed outside the tank adjacent to a bottom wall of the tank, and an x-ray image of station 300 will include a simulated spinal shadow caused by spinal simulation features 4604 .
  • a surgical simulation device 202 may be provided that includes a station 300 having a housing 309 , a tank 306 formed in the housing and configured to receive a patient-specific cartridge 308 that includes a patient-specific model 2502 of at least a portion of a heart of a patient, where the tank 306 has a bottom wall 4700 having a first surface that forms a bottom surface 1402 of the tank, and an opposing second surface, an esophageal access system 700 extending within the housing between an esophageal access port 304 on the housing and a first port 714 in the tank, a vascular access system 302 including a first end with a vascular access port 310 and a second end configured to be fluidly coupled to a second port 718 in the tank, and a spinal shadow simulation card 4600 disposed within the housing 309 adjacent the opposing second surface of the bottom wall 4700 of the tank.
  • the patient-specific model 2502 includes mechanical and acoustic features that correspond to mechanical and acoustic features of the heart of the patient.
  • the esophageal access system 700 is configured to allow access to the tank 306 by an ultrasound probe 505 for ultrasound imaging of the patient-specific cartridge 308 .
  • FIGS. 48-57 illustrate various aspects of fluid flow control system 909 of a physical simulator device 202 .
  • FIG. 48 illustrates a schematic view of a fluid flow control system 909 that includes an outlet pipe 4804 and an inlet pipe 4814 fluidly coupled to tank 306 via openings 4800 and 4802 of a physical simulator device 202 (e.g., corresponding to openings 1406 and 1410 of FIG. 14 , respectively).
  • outlet pipe 4804 includes a filter 4806 , and a pump 4808 that controls the flow of blood simulation fluid 307 through pipes 4804 and 4814 and tank 306 .
  • inlet pipe 4814 includes a chamber 4810 having an air cavity 4812 for removal of air bubbles from the blood simulation fluid 307 that could otherwise negatively impact ultrasound imaging.
  • FIG. 49 illustrates a schematic view of another implementation of fluid flow control system 909 in which an additional outlet pipe 4909 extending between additional opening 4905 to filter 4806 , and a heater 4900 coupled to a power supply 4902 are provided.
  • Heater 4900 may be powered by power supply 4902 (e.g., a battery within station 300 ) to heat blood simulation fluid 307 (e.g., to approximately 37.5 degrees Celsius).
  • a fluid control system 909 is provided in the station 300 , and configured to circulate a blood simulation fluid 307 through the tank 306 at least a portion of the patient-specific model 2502 .
  • the fluid control system 909 includes an outlet pipe (e.g., pipe 4804 and/or 4909 ) coupled to a first opening (e.g., 4800 or 4905 ) in the tank, an inlet pipe (e.g., pipe 4814 ) coupled to a second opening (e.g., opening 4802 ) in the tank, and a pump 4808 configured to move the blood simulation fluid 307 through the inlet pipe, the tank, and the outlet pipe.
  • the fluid control system 909 may also include a filter 4806 on the outlet pipe.
  • the fluid control system may also include a heater 4900 disposed between the pump 4808 and the second opening.
  • the fluid control system 909 may also include a chamber 4810 having an air cavity 4812 disposed between the pump and the second opening and/or between the heater and the second opening.
  • FIG. 50 schematically illustrates a functional procedure of the heating system for the station 300 , including during a preparation operation, a use operation, and a flush operation.
  • the preparation operation may include operation of an accessory fluid heater temporarily attached to the station 300 , according to aspects of the disclosure.
  • FIG. 51 illustrates a perspective view of an accessory fluid heater 5100 that can be provided for a physical simulator device 202 , according to aspects of the disclosure.
  • an accessory heater 5100 may include a mounting structure 5102 configured to removably attach to a sidewall 5110 of station 300 , and configured to hold a temperature sensor 5104 , and a resistive heating element 5106 within fluid 307 in tank 306 .
  • FIG. 52 illustrates a cross-sectional view of a mounting member 5102 , installed on sidewall 5110 of station 300 .
  • mounting member 5102 may be arranged to wrap around and over the top of sidewall 5110 (e.g., secured by a friction fit), while holding temperature sensor 5104 and resistive heating element 5106 in a desired position.
  • Resistive heating element 5106 may be provided in tank 305 , in a feedback loop with temperature sensor 5104 , to rapidly heat the blood simulation fluid 307 (e.g., to 37.5 degrees Celsius) prior to a simulated surgical procedure, the fluid thereafter being held at the desired temperature by internal heater 4900 (see FIG. 49 ).
  • Resistive heating element 5106 may be powered by an external power source 5108 .
  • FIGS. 53A, 53B, and 53C illustrate various features of another implementation of an accessory heater for physical simulator device 202 .
  • an accessory heater 5300 may be provided that includes two mounting portions 5304 , configured to wrap around and over opposing sidewalls 5110 and 5112 of station 300 , and a cap portion 5302 extending between the two mounting portions 5304 .
  • FIG. 53B illustrates a cross-sectional view of a mounting portion 5304 of the accessory fluid heater 5300 of FIG. 53A .
  • mounting portion 5304 may include a first vertical extension 5308 having a first magnet 5306 and a second vertical extension 5310 having a second magnet 5313 .
  • sidewall 5112 of tank 306 may include magnets 5309 and 5311 configured to magnetically engage with magnets 5306 and 5313 of mounting portion 5304 to temporarily secure accessory heater 5300 to tank 306 .
  • Sidewall 5110 may include magnets similar to magnets 5309 and 5311 , for magnetically engaging with magnets in the other mounting portion 5304 of accessory heater 5300 . As shown in FIG.
  • a resistive heating element 5390 may extend from cap portion 5302 into blood simulation fluid 307 (when mounting portions 5304 are mounted to sidewalls 5110 and 5112 ) to rapidly heat fluid 307 (e.g., to 37.5 degrees Celsius) prior to a simulated surgical procedure.
  • physical simulator device 202 may include a flush system 5400 configured to couple to station 300 for flushing blood simulation fluid 307 from station 300 .
  • flush system 5400 may include external flush tubing 5404 that extends between a flush valve 5402 and a flush receptacle 5406 .
  • flush system 5400 may include an external flush pump (e.g., as shown on flush tubing 5404 if FIG. 54 ).
  • station 300 may include a pump that can be used for flushing fluid to fluid tubing 5404 .
  • FIG. 55 shows how, internally to station 300 , fluid flow system 909 may include a Y-pipe 5500 at an intersection between outlet pipe 4804 and inlet pipe 4814 before flush valve 5402 .
  • FIG. 55 includes arrows that illustrate the fluid flow within outlet pipe 4804 and inlet pipe 4814 (noting that other features of fluid control system 909 such as heater 4900 , pump 4808 , and chamber 4810 are not shown in FIG. 55 for clarity of the present description) when flush valve 5402 is closed.
  • FIG. 56 includes arrows that illustrate the fluid flow within outlet pipe 4804 , inlet pipe 4814 , and flush tubing 5404 when flush valve 5402 is open.
  • FIG. 55 and 56 each also include an enlarged view of Y-pipe 5500 showing how the Y-pipe may include a restricted portion 5509 between outlet pipe 4804 and flush portion 5512 , at the location of the intersection with a return section 5510 to inlet pipe 4814 , to create a venturi effect to help facilitate flushing of the system.
  • FIG. 57 illustrates a cross-sectional perspective view showing further details of the constriction of Y-pipe 5500 .
  • the venturi effect generated by the constriction of the Y-pipe 5500 allows pump 4808 in the station 300 to be used to circulate fluid within the station, and to generate an aspiration to flush the station.
  • the constriction 5509 may narrow the diameter of pipe 4804 from, for example, approximately 10 mm to approximately 8 mm, 6 mm, or 4 mm (as examples).
  • the fluid control system 909 includes a Y-pipe 5500 disposed between the flush valve 5402 and both the inlet pipe 4814 and the outlet pipe 4804 for tank 306 .
  • FIG. 58 illustrates a schematic side view of a patient-specific cartridge during installation in a tank of a station of a physical simulator device.
  • distal support 3110 of patient-independent frame 2500 may first be placed into position against access port 718 in sidewall 1491 of tank 306 , while base portion 3108 of frame 2500 is rotated toward bottom wall 4700 of tank 306 , until base portion 3108 contacts bottom wall 4700 and portion 3112 is in contact with sidewall 1489 , as shown in FIG. 59 .
  • FIG. 60 shows how portion 3112 of frame 2500 can include engagement features such as magnets 6000 .
  • sidewall 1489 of tank 306 may be provided with corresponding engagement features 6100 for engagement with engagement features 6000 on frame 2500 , to secure cartridge 308 within tank 306 .
  • FIG. 62 includes arrows 6200 illustrating a magnetic engagement between portion 3112 of frame 2500 and sidewall 1489 of tank 306 .
  • Magnets 6000 disposed on the patient-independent frame 2500 (e.g., along with magnets 6100 in the sidewall of tank 306 ) help facilitate plug-and-play installation and removal of the patient-specific cartridge 308 in the surgical simulator device 202 .
  • the frame 2500 includes a base portion 3108 configured to abut a bottom surface 1402 of the tank 306 when the patient-specific cartridge 308 is installed in the tank.
  • the frame 2500 also includes an opening 2609 configured to align with an access port 718 on a first sidewall 1491 of the tank 306 , and a proximal portion 3112 including at least one engagement member (e.g., one or more of magnets 6000 ) configured to engage with a corresponding engagement member (e.g., one or more of magnets 6100 ) on an opposing second sidewall 1489 of the tank 306 .
  • FIG. 63 shows how, when magnetic engagement between portion 3112 of frame 2500 and sidewall 1489 of tank 306 holds a first side of frame 2500 in place within tank 306 , an engagement between access port 718 and distal portion 3110 of frame 2500 may hold the opposing side of frame 2500 in place within tank 306 .
  • a method includes providing a surgical simulation device 202 having a station 300 having a housing 309 , a tank 306 formed in the housing 309 , and a vascular access system 302 coupled to the housing.
  • the method may include providing, in the tank 306 , a patient-specific cartridge 308 that includes a patient-specific model 2502 of at least a portion of a heart of a patient.
  • the method may also include inserting an imaging device, such as an ultrasound probe 505 , through an esophageal access system 700 within the housing from an esophageal access port 304 on the housing, though a first port 714 in the tank, and into a recess 1400 in a bottom surface 1402 of the tank 306 beneath the patient-specific cartridge 308 .
  • the method may also include inserting a surgical element (e.g., a guidewire and/or one or more cardiac interventional devices) from a vascular access port 310 of the vascular access system 302 , through a main lumen 1700 of the vascular access system, and into a portion of the patient-specific model 2502 via a second port 718 in the tank 306 .
  • a surgical element e.g., a guidewire and/or one or more cardiac interventional devices
  • the method may also include, prior to providing the patient-specific cartridge 308 in the tank 306 , coupling first, second, and third interfacing portions 3100 , 3103 , and 3102 of the patient-specific model 2502 to corresponding first, second, and third openings 2609 , 2611 , and 2613 in a frame 2500 of the patient-specific cartridge 308 .
  • the method may also include circulating a blood simulation fluid 307 through the tank 306 and at least portions of the patient-specific model 2502 (e.g., using fluid control system 909 ).
  • the method may also include heating the blood simulation fluid 307 with a heater 4900 in the station 300 .
  • the method may also include, prior to heating the blood simulation fluid 307 with the heater 4900 in the station 300 , pre-heating the blood simulation fluid 307 with an accessory heater (e.g., accessory heater 5100 or accessory heater 5300 ) configured to attach to at least one sidewall 5110 of the station 300 .
  • the method may also include obtaining fluoroscopy images of the patient-specific cartridge 308 using x-ray attenuating material in or one the patient-specific model 2502 , while the patient-specific cartridge is in the tank.
  • the patient-specific model may include a right atrium, a septum, and a left atrium, and the method may include inserting, via the second port in the tank, the surgical element into the right atrium of the patient-specific model.
  • the method may also include puncturing the septum of the patient-specific model with the surgical element.
  • the method may also include passing a device through the punctured septum into the left atrium of the patient-specific model.
  • the patient-specific model may also include a left atrial appendage, and the method may also include occluding the left atrial appendage of the patient-specific model with the device.
  • the septum, the left atrium, and the left atrial appendage of the patient-specific model have mechanical and acoustic characteristics that correspond to mechanical and acoustic characteristics, respectively, of a septum, a left atrium, and a left atrial appendage of the patient.
  • the method may also include generating an ultrasound image of the patient-specific cartridge using the imaging device.
  • Implementations of portions of the subject matter and the operations described in this specification can be implemented in digital electronic circuitry, or in computer software embodied on a tangible medium, firmware, or hardware, including the structures disclosed in this specification and their structural equivalents, or in combinations of one or more of them. Implementations of portions of the subject matter described in this specification can be implemented as one or more computer programs embodied on a tangible medium, i.e., one or more modules of computer program instructions, encoded on one or more computer storage media for execution by, or to control the operation of, a data processing apparatus.
  • a computer storage medium can be, or be included in, a computer-readable storage device, a computer-readable storage substrate, a random or serial access memory array or device, or a combination of one or more of them.
  • the computer storage medium can also be, or be included in, one or more separate components or media (e.g., multiple CDs, disks, or other storage devices).
  • the computer storage medium may be tangible and non-transitory.
  • references to “or” may be construed as inclusive so that any terms described using “or” may indicate any of a single, more than one, and all of the described terms.
  • the labels “first,” “second,” “third,” and so forth are not necessarily meant to indicate an ordering and are generally used merely to distinguish between like or similar items or elements.

Landscapes

  • Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Computational Mathematics (AREA)
  • Mathematical Optimization (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Algebra (AREA)
  • Theoretical Computer Science (AREA)
  • Educational Technology (AREA)
  • Mathematical Analysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Mathematical Physics (AREA)
  • Pure & Applied Mathematics (AREA)
  • Business, Economics & Management (AREA)
  • Educational Administration (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Instructional Devices (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
US17/278,049 2018-09-20 2019-09-20 Patient-specific cardiovascular simulation device Abandoned US20210350723A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/278,049 US20210350723A1 (en) 2018-09-20 2019-09-20 Patient-specific cardiovascular simulation device

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862734223P 2018-09-20 2018-09-20
US17/278,049 US20210350723A1 (en) 2018-09-20 2019-09-20 Patient-specific cardiovascular simulation device
PCT/IB2019/001029 WO2020058760A1 (en) 2018-09-20 2019-09-20 Patient-specific cardiovascular simulation device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2019/001029 A-371-Of-International WO2020058760A1 (en) 2018-09-20 2019-09-20 Patient-specific cardiovascular simulation device

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US18/365,070 Continuation US20230386363A1 (en) 2018-09-20 2023-08-03 Patient-specific cardiovascular simulation device

Publications (1)

Publication Number Publication Date
US20210350723A1 true US20210350723A1 (en) 2021-11-11

Family

ID=68655563

Family Applications (2)

Application Number Title Priority Date Filing Date
US17/278,049 Abandoned US20210350723A1 (en) 2018-09-20 2019-09-20 Patient-specific cardiovascular simulation device
US18/365,070 Pending US20230386363A1 (en) 2018-09-20 2023-08-03 Patient-specific cardiovascular simulation device

Family Applications After (1)

Application Number Title Priority Date Filing Date
US18/365,070 Pending US20230386363A1 (en) 2018-09-20 2023-08-03 Patient-specific cardiovascular simulation device

Country Status (6)

Country Link
US (2) US20210350723A1 (ja)
EP (1) EP3853837A1 (ja)
JP (1) JP2022501643A (ja)
CN (1) CN113454695A (ja)
AU (1) AU2019343335A1 (ja)
WO (1) WO2020058760A1 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11257397B2 (en) * 2017-06-09 2022-02-22 Board Of Regents Of The University Of Nebraska Transesophageal echocardiography simulator
US11417240B2 (en) * 2019-06-21 2022-08-16 Bernhard Meyer Training device for simulating a vascular bed through which flow passes, and associated method
WO2024003692A1 (en) * 2022-07-01 2024-01-04 Upsurgeon S.R.L. Surgical simulation device, surgical simulation learning system, cartridge for a surgical simulation device, and method for producing said cartridge

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4272201A1 (en) * 2020-12-30 2023-11-08 Biomodex, S.A.S. System for advanced physician training and patient specific rehearsals
WO2022208470A1 (en) * 2021-04-02 2022-10-06 Biomodex, S.A.S. Patient specific cardiovascular simulation device
WO2022219545A1 (en) * 2021-04-13 2022-10-20 Biomodex, S.A.S. Patient specific aortic procedure simulation device

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870666A (en) * 1986-08-07 1989-09-26 General Electric Company Computer tomographic phantom
US6224619B1 (en) * 1991-12-17 2001-05-01 Heartport, Inc. Blood vessel occlusion trocar having size and shape varying insertion body
US6071269A (en) * 1998-05-13 2000-06-06 Medisystems Technology Corporation Blood set and chamber
US6302582B1 (en) * 1998-12-22 2001-10-16 Bio-Imaging Technologies, Inc. Spine phantom simulating cortical and trabecular bone for calibration of dual energy x-ray bone densitometers
US6234804B1 (en) * 1999-03-02 2001-05-22 Peter Yong Thoracic training model for endoscopic cardiac surgery
US6488507B1 (en) * 1999-11-29 2002-12-03 Ethicon, Inc. Portable surgical trainer
US7850454B2 (en) * 2000-10-23 2010-12-14 Toly Christopher C Simulated anatomical structures incorporating an embedded image layer
US6517524B2 (en) * 2001-02-15 2003-02-11 Genesse Biomedical, Inc. Occlusive cannula for aortic blood flow and air venting
ATE446061T1 (de) * 2003-04-24 2009-11-15 Cook Inc Künstliche klappe für blutgefäss mit verbessertem fliessverhalten
US7877128B2 (en) * 2005-08-02 2011-01-25 Biosense Webster, Inc. Simulation of invasive procedures
WO2007097247A1 (ja) * 2006-02-24 2007-08-30 Hrs Consultant Service, Inc. 経食道心エコー診断教育装置
CN100493460C (zh) * 2007-04-12 2009-06-03 中国人民解放军第三军医大学第一附属医院 一种虚拟经食道超声心动图***
US9262943B2 (en) * 2008-03-26 2016-02-16 Oneal Clash CPR mannequin
US10360817B2 (en) * 2010-06-30 2019-07-23 Stuart Charles Segall Wearable partial task surgical simulator
US10311978B2 (en) * 2012-01-30 2019-06-04 Siemens Healthcare Gmbh Method and system for patient specific planning of cardiac therapies on preoperative clinical data and medical images
US10229615B2 (en) * 2012-01-31 2019-03-12 Vascular Simulations Inc. Cardiac simulation device
US20130288218A1 (en) * 2012-04-27 2013-10-31 Medtronic Cryocath Lp Cardiac model for simulating medical procedures
CN102789732B (zh) * 2012-08-08 2014-08-06 四川大学华西医院 用于教学及临床技能培训的经食管超声可视化仿真***与方法
WO2014179556A1 (en) * 2013-05-01 2014-11-06 Northwestern University Surgical simulators and methods associated with the same
WO2015200552A1 (en) * 2014-06-25 2015-12-30 William Beaumont Hospital Simulated cardiac model
CN106463067B (zh) * 2014-11-10 2020-04-28 国立大学法人大阪大学 导管仿真器以及导管仿真器用造影方法
WO2016158222A1 (ja) * 2015-03-30 2016-10-06 国立大学法人大阪大学 カテーテル・シミュレーター用容器、及びこの容器内に収容される心臓モデル
EP3333833B1 (en) * 2015-08-03 2022-03-23 Terumo Kabushiki Kaisha Technique simulator
US10198969B2 (en) * 2015-09-16 2019-02-05 KindHeart, Inc. Surgical simulation system and associated methods
EP3516551A1 (en) 2016-09-19 2019-07-31 Biomodex Method for fabricating a physical simulation device, simulation device and simulation system
EP3296899A1 (en) 2016-09-19 2018-03-21 Biomodex S.A.S. Method and apparatus for generating a 3d model of an object
CN109716419B (zh) * 2016-10-28 2022-01-11 国立大学法人大阪大学 导管-模拟器用内脏器官模型
CA3084007A1 (en) * 2016-12-31 2018-07-05 Richard D. TALLMAN, Jr. Heart simulation system for medical services or diagnostic machines

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11257397B2 (en) * 2017-06-09 2022-02-22 Board Of Regents Of The University Of Nebraska Transesophageal echocardiography simulator
US11417240B2 (en) * 2019-06-21 2022-08-16 Bernhard Meyer Training device for simulating a vascular bed through which flow passes, and associated method
WO2024003692A1 (en) * 2022-07-01 2024-01-04 Upsurgeon S.R.L. Surgical simulation device, surgical simulation learning system, cartridge for a surgical simulation device, and method for producing said cartridge

Also Published As

Publication number Publication date
US20230386363A1 (en) 2023-11-30
AU2019343335A1 (en) 2021-05-20
EP3853837A1 (en) 2021-07-28
WO2020058760A1 (en) 2020-03-26
CN113454695A (zh) 2021-09-28
JP2022501643A (ja) 2022-01-06

Similar Documents

Publication Publication Date Title
US20230386363A1 (en) Patient-specific cardiovascular simulation device
Vukicevic et al. Cardiac 3D printing and its future directions
US20210100619A1 (en) Method of analyzing hollow anatomical structures for percutaneous implantation
Giannopoulos et al. Cardiothoracic applications of 3-dimensional printing
Kim et al. Three-dimensional printing: basic principles and applications in medicine and radiology
JP7019694B2 (ja) 医療処置で使用するための医療装置の選択
Laing et al. Patient-specific cardiac phantom for clinical training and preprocedure surgical planning
JP2010513977A (ja) 解剖学的及び機能的に正確な軟組織ファントム並びにその製造方法
US20170278429A1 (en) Anatomical ultrasound access model
Gomes et al. Use of 3D printing in preoperative planning and training for aortic endovascular repair and aortic valve disease
CN112368760A (zh) 回声器官复制品和使用增材制造***的制造方法
Gómez-Ciriza et al. Affordable three-dimensional printed heart models
RU2691524C1 (ru) Симулятор для освоения навыков выполнения операций на почке
Fidvi et al. Advanced 3D visualization and 3D printing in radiology
Tabaczynski Mechanical assessment of 3D printed patient specific phantoms for simulation of minimally invasive image guided procedures
Kim et al. Novel resectable myocardial model using hybrid three-dimensional printing and silicone molding for mock myectomy for apical hypertrophic cardiomyopathy
US20230136820A1 (en) MULTl-MATERIAL THREE-DIMENSIONAL PRINTED PORTION OF A HEART
US20220084440A1 (en) 3D Physical Replica Of A Cardiac Structure And A Method For Manufacturing The Same
WO2022208470A1 (en) Patient specific cardiovascular simulation device
Linte et al. Image-guided procedures: tools, techniques, and clinical applications
Laing A patient-specific cardiac phantom for training and pre-procedure surgical planning
JPWO2016158222A1 (ja) カテーテル・シミュレーター用容器、及びこの容器内に収容される心臓モデル
Tredway et al. 3D printing applications for percutaneous structural interventions in congenital heart disease
US20240071253A1 (en) System for advanced physician training and patient specific rehearsals
Groves et al. A review of low-cost ultrasound compatible phantoms

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE